The SH2-domain-containing Inositol 5'-Phosphatase-1 (SHIP) has the potential to modulate multiple signaling pathways downstream of receptors that impact hematopoietic stem cell (HSC) biology. Therefore, we postulated that SHIP might play an important role in HSC homeostasis and function. Consistent with this hypothesis, HSC proliferation and numbers are increased in SHIP -/-mice. Despite expansion of the compartment, SHIP -/-HSC exhibit reduced capacity for long-term repopulation.
Introduction
The survival of an organism is dependent upon the ability of hematopoietic stem cells (HSC) to replenish the blood compartment on a daily basis. To accomplish this task, HSC must maintain a fine balance between three possible fates: self-renewal, differentiation or senescence. Although the decision process that determines the fate of an HSC clone remains to be completely defined, several molecules are already known to play a role in this process, including components of the HSC microenvironment or niche.
This niche consists of both extra-cellular matrix molecules and cells, such as osteoblasts and stromal cells that produce cytokines and chemokines important for the maintenance of the HSC pool. [1] [2] [3] [4] [5] These microenvironmental or external cues engage receptors on HSC, leading to the activation of signaling pathways governing cell proliferation, self-renewal, differentiation, mobilization and BM retention. 5 Some of these pathways, such as those initiated by Stem Cell Factor (SCF/c-kitL), 6 stromal cell derived factor 1 (SDF-1/CXCL12) 7 and thrombopoietin (TPO), 8 result in the activation of phosphatidylinositol 3' kinase (PI3K) and the formation of phosphatidyl inositol 3,4,5-trisphosphate (PIP3).
Therefore, the SH2 domain-containing Inositol 5'-Phosphatase 1 (SHIP) may influence these pathways in HSC. 9, 10 SHIP is a 145 kDa protein primarily expressed by cells of the hematopoietic system, 11 including HSC, 12 that can associate with various adapter proteins, scaffold proteins, or receptors following activation of hematopoietic cells. 9, 13 Formation of these complexes enables SHIP to hydrolyze the 5'phosphate on PIP3, 11, 14 thus preventing membrane recruitment and activation of pleckstrin homology domain
For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From containing kinases that serve as effectors of PI3K signaling. This activity permits SHIP to limit the survival, activation, differentiation and/or proliferation of hematopoietic cells. 10 Thus, we hypothesized that SHIP might also influence these processes in the HSC compartment. Previous studies reported that SHIP -/-whole bone marrow (WBM) cells do not reconstitute lethally irradiated mice as well as wild-type (WT) WBM in a non competitive setting. 15 Furthermore it was reported that SHIP -/-WBM has comparable numbers of competitive-repopulating-units (CRU) relative to WT littermates in a limiting-dilution assay, which uses compromised competitor cells. 15 However, because these analyses were performed with WBM rather than purified HSC, they did not assess whether SHIP -/-HSC are defective for repopulation in a WT environment. Thus, it is not possible from these previous studies to conclude that SHIP plays a direct role in signaling pathways active in the HSC compartment.
To study the effects of SHIP on HSC we used SHIP -/-mice generated by a Cre-lox mutation strategy. 16 We found that SHIP -/-mice contain significantly more HSC in their bone marrow and spleen as measured by flow cytometry. We also observe that a greater proportion of SHIP -/-HSC enter the cell cycle compared to WT HSC. Since it was shown in previous studies that SHIP -/-BM contains reduced HSC activity relative to WT BM, 15 it became important to assess the function of SHIP -/-HSC with different assays. We find that when purified SHIP -/-HSC or WBM are transplanted into lethally irradiated mice, they fail to compete effectively with WT HSC or BM cells for long-term multi-lineage repopulation of the hematopoietic compartment. These results might have suggested that the absence of SHIP causes accelerated senescence of the HSC compartment, however, 
Materials and Methods
Mice SHIP -/-mice were generated by deletion of the promoter and first exon of SHIP via a CreLoxP strategy and then backcrossed to the C57BL6/J background. 16 Animal experiments were conducted in compliance with institutional guidelines at the University of South Florida.
Cell isolation
BM cells are flushed from intact femurs and tibia and spleens are crushed with a syringe plunger, the cells are collected in tissue media (TM); RPMI, 3%FBS, 10mM HEPES (Invitrogen; Gibco BRL, Carlsbad, CA, USA). Cells were then filtered through a 70µm strainer (BD Bioscience, San Jose, CA, USA) and red blood cells (RBC) were lysed at room temperature (RT) for 2-5 minutes in 1xRBC lysis buffer (Ebioscience, San Diego, CA), centrifuged, and resuspended in staining media (SM): 1xD-PBS, 3% FBS, 10mM HEPES (Invitrogen, Gibco BRL). Peripheral blood (PB) was obtained by retro-orbital (RO) or sub-mandibular bleeding, collected in microtainers with K 2 EDTA (BD, Franklin Lakes, NJ, USA), and RBC lysed twice to obtain PB mononuclear cells (PBMC), which were resuspended in SM.
HSC phenotype
All antibodies were from BD Biosciences (San Diego, CA, USA) except where noted. In vivo homing assay 27, 28 For personal use only. 
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-/-BM cells show decreased ability to reconstitute the hematopoietic compartment of lethally irradiated recipients.
It was previously reported that SHIP -/-BM cells have a lower ability to reconstitute irradiated mice after transplantation, but contains similar CRU activity as compared to WT BM when measured by limiting-dilution assay. 15 Since these results are inconsistent with our finding that SHIP -/-BM contains increased number of HSC ( Figure   1 ), we addressed this discrepancy by measuring the ability of SHIP -/-HSC to accomplish long-term multi-lineage repopulating activity. We first performed a well-defined CRU assay as described by Harrison 25 to assess the level of repopulation activity in WBM.
WBM is used for the CRU assay and therefore is not dependent on isolation of HSC based on cell surface markers, whose expression can be altered by genetic mutation of Measuring HSC activity by transplantation of WBM from mutant mice can be confounded by the fact that the mutation can endow lineage-committed progenitor cells with properties that may obscure the observation of compromised HSC function. 34 This is a concern when working with SHIP -/-BM as the SHIP mutation enhances myelopoiesis, leading to an increase in myeloid progenitors with enhanced survival. 35 Therefore, analysis of HSC activity in SHIP -/-mice must also be assessed with purified HSC to rule out these potential experimental artifacts. To directly assess whether SHIP expression by HSC is required for long-term multi-lineage repopulation and self-renewal, we directly compared the repopulating potential of purified HSC from SHIP -/-and WT (Figure 2g ). These results demonstrate that SHIP expression is required by HSC in order to sustain long-term multi-lineage repopulation.
SHIP -/-HSC have a lower rate of spontaneous apoptosis.
It was reported that SHIP -/-mice have increased osteoporosis caused by an increase in osteoclast activity. 36 The HSC niche is dependent on the presence of osteoblasts, the counter part of osteoclasts, to properly sustain the hematopoietic compartment. 2 Thus, any disruption of the balance between osteoblasts and osteoclasts could destroy the niche necessary for HSC survival, resulting in anoikis-associated apoptosis of the HSC compartment. If SHIP -/-HSC exhibited increased apoptosis, this (Figure 3b) . Thus, the lack of long-term repopulating activity of SHIP -/-HSC activity appears not to be associated with anoikisinduced apoptosis of the compartment.
In vivo homing of SHIP -/-stem/progenitors to the BM is significantly reduced as compared to WT.
We considered that the diminished repopulation observed for SHIP -/-HSC could result from an inefficiency of SHIP -/-HSC to home and be retained in the BM niche. Moreover, SHIP -/-myeloid and hematopoietic progenitor cells are hyper-responsive to several of these factors. 13 The enhanced survival and proliferation of SHIP -/-HSC could
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partially explain the decreased repopulating ability of these cells as it was shown that cycling HSC engraft less efficiently than resting HSC. 31, 47, 48 Homing and eventual engraftment of HSC following transplantation has been shown to rely on the expression and activity of several surface molecules, including VLA-4, VLA-5 and CXCR4. 17, 49, 50 The CXCR4 receptor induces cell migration towards an increasing gradient of SDF-1/CXCL12. 51 Treatment of NOD/SCID mice with SDF-1 leads to the mobilization of HSC to PB 52 and treatment of human HSC with anti-CXCR4
antibody prior to transplantation in NOD/SCID mice results in HSC engraftment failure. 17 In addition, one of the ligands for VLA-4, VCAM-1, which is usually found on stromal/endothelial cells, has been shown to be expressed in hematopoietic cells such as Mac-1 + , B220 + and, more interestingly, cKit + cells. 19 Even though the role of VCAM-1 on hematopoietic stem/progenitor cells remains to be fully elucidated, there is evidence that it is involved in their retention in the BM, as shown for B cell progenitors. 19 With that information in mind, the reduction in the percentage of HSC expressing CXCR4 and VCAM-1 receptors in SHIP -/-BM can provide a basis for the decrease in SHIP -/-HSC ability to home to the BM, as shown by our in vivo homing assays (Figure 4b ). This inefficiency of SHIP -/-HSC to reach and be retained in the HSC niche could contribute to their impaired self-renewal and long-term repopulating capacity. In previous studies, in vitro stimulation of murine BM stem/progenitor cells with different cytokines was shown to induce cell cycle, decrease VLA-4 expression and compromise engraftment. 47 In our study, the increase in HSC cell cycle observed in vivo did not necessarily correlate with a decrease in VLA-4 expression, but caused a decline in long-term engraftment capacity. The CRU assay included in this study showed a decrease in the repopulating ability of SHIP -/-WBM, while previous studies revealed that SHIP -/-WBM had comparable repopulating activity in a limiting-dilution CRU assay. 15 The different results observed between the two CRUs might stem from the variation in the assays themselves. In the Harrison CRU assay, healthy competitor cells are utilized, while the For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From
